NCT02550717View on ClinicalTrials.gov

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)

CompletedOBSERVATIONAL
Enrollment

398,158

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Secondary PreventionStrokeIschemic Heart DiseaseCoronary Heart Disease
Interventions
DRUG

Acetylsalicylic Acid (Aspirin, BAYE4465)

Low-dose ASA for secondary prevention of cardiovascular events

DRUG

Clopidogrel, Oral Anticoagulants, NSAIDs and SSRIs

Secondary prevention of cardiovascular events

Trial Locations (1)

Unknown

Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY